NOD2/CARD15 Variants Are Not a Risk Factor for Clinical Outcome after Nonmyeloablative Allogeneic Stem Cell Transplantation

Hanneke M. van der Straaten, Martine M. Paquay, Marcel G. J. Tilanus, Nan van Geloven, Leo F. Verdonck, Cynthia Huisman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1231-1236
JournalBiology of Blood and Marrow Transplantation
Volume17
Issue number8
DOIs
Publication statusPublished - Aug 2011

Keywords

  • NOD2/CARD15
  • Polymorphisms
  • Nonmyeloablative allogeneic stem cell transplantation
  • SNP

Cite this